These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 16850797

  • 41. [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
    Weizel A, Sawicki PT.
    MMW Fortschr Med; 2004 Dec 16; 146(51-52):14, 16. PubMed ID: 15675236
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins.
    Prescrire Int; 2003 Aug 16; 12(66):143-8. PubMed ID: 12908497
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Optimal lipid lowering therapy for coronary heart diseases patients in secondary prevention: moderate or aggressive LDL decrease preferred?].
    MMW Fortschr Med; 2006 Nov 30; 148(48):54-5. PubMed ID: 17615773
    [No Abstract] [Full Text] [Related]

  • 46. Benefits of atorvastatin in cholesterol lowering.
    Farmer JA.
    Curr Atheroscler Rep; 2003 Mar 30; 5(2):94-5. PubMed ID: 12573192
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J.
    Ann Cardiol Angeiol (Paris); 1999 Feb 30; 48(2):128-36. PubMed ID: 12555337
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Atorvastatin].
    Kajinami K, Takekoshi N.
    Nihon Rinsho; 2001 Mar 30; 59 Suppl 3():598-604. PubMed ID: 11347138
    [No Abstract] [Full Text] [Related]

  • 54. [High dosage stain protects heart and brain from recurrence].
    MMW Fortschr Med; 2008 Nov 27; 150(48):118-9. PubMed ID: 19125516
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Aggressive lipid-lowering regimen halts CHD progression.
    Geriatrics; 2004 Jan 27; 59(1):44. PubMed ID: 14755869
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Cholesterol limbo: How low should the bar go. Ratcheting down LDL to extra-low levels with high-dose statins seems to work wonders.
    Harv Health Lett; 2004 May 27; 29(7):1-2. PubMed ID: 15153394
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.